Literature DB >> 29911893

Effects of an intensive long-term prevention programme after myocardial infarction - a randomized trial.

Harm Wienbergen1, Andreas Fach1, Sven Meyer2, Jochen Meyer3, Janina Stehmeier1, Tina Backhaus1, Stephan Michel1, Kirsten Krämer1, Rico Osteresch1, Johannes Schmucker1, Henning Haase4, Tobias Härle2, Albrecht Elsässer2, Rainer Hambrecht1.   

Abstract

BACKGROUND: Long-term risk factor control after myocardial infarction (MI) is currently inadequate and there is an unmet need for effective secondary prevention programmes. DESIGN AND METHODS: It was the aim of the study to compare a 12-month intensive prevention programme (IPP), coordinated by prevention assistants and including education sessions, telephone visits and telemetric risk factor control, with usual care after MI. Three hundred and ten patients were randomized to IPP vs. usual care one month after hospital discharge for MI in two German heart centres. Primary study endpoint was the IPP Prevention Score (0-15 points) quantifying global risk factor control.
RESULTS: Global risk factor control was strongly improved directly after MI before the beginning of the randomized study (30% increase IPP Prevention Score). During the 12-month course of the randomized trial the IPP Prevention Score was improved by a further 14.3% in the IPP group ( p < 0.001), while it decreased by 11.8% in the usual care group ( p < 0.001). IPP significantly reduced smoking, low-density lipoprotein cholesterol, systolic blood pressure and physical inactivity compared with usual care ( p < 0.05). Step counters with online documentation were used by the majority of patients (80%). Quality of life was significantly improved by IPP ( p < 0.05). The composite endpoint of adverse clinical events was slightly lower in the IPP group during 12 months (13.8% vs. 18.9%, p = 0.25).
CONCLUSIONS: A novel intensive prevention programme after MI, coordinated by prevention assistants and using personal teachings and telemetric strategies for 12 months, was significantly superior to usual care in providing sustainable risk factor control and better quality of life.

Entities:  

Keywords:  Acute myocardial infarction; intensive prevention programme; prevention score; telemetric control

Year:  2018        PMID: 29911893     DOI: 10.1177/2047487318781109

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  4 in total

Review 1.  Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.

Authors:  Massimo F Piepoli
Journal:  Eur J Prev Cardiol       Date:  2020-07       Impact factor: 7.804

Review 2.  Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 1.

Authors:  Bernhard Rauch; Annett Salzwedel; Birna Bjarnason-Wehrens; Christian Albus; Karin Meng; Jean-Paul Schmid; Werner Benzer; Matthes Hackbusch; Katrin Jensen; Bernhard Schwaab; Johann Altenberger; Nicola Benjamin; Kurt Bestehorn; Christa Bongarth; Gesine Dörr; Sarah Eichler; Hans-Peter Einwang; Johannes Falk; Johannes Glatz; Stephan Gielen; Maurizio Grilli; Ekkehard Grünig; Manju Guha; Matthias Hermann; Eike Hoberg; Stefan Höfer; Harald Kaemmerer; Karl-Heinz Ladwig; Wolfgang Mayer-Berger; Maria-Inti Metzendorf; Roland Nebel; Rhoia Clara Neidenbach; Josef Niebauer; Uwe Nixdorff; Renate Oberhoffer; Rona Reibis; Nils Reiss; Daniel Saure; Axel Schlitt; Heinz Völler; Roland von Känel; Susanne Weinbrenner; Ronja Westphal
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

3.  Nurse-based secondary preventive follow-up by telephone reduced recurrence of cardiovascular events: a randomised controlled trial.

Authors:  Anna-Lotta Irewall; Anders Ulvenstam; Anna Graipe; Joachim Ögren; Thomas Mooe
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

Review 4.  Effects of Supervised Cardiac Rehabilitation Programmes on Quality of Life among Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.

Authors:  María Mansilla-Chacón; José L Gómez-Urquiza; María Begoña Martos-Cabrera; Luis Albendín-García; José L Romero-Béjar; Guillermo A Cañadas-De La Fuente; Nora Suleiman-Martos
Journal:  J Cardiovasc Dev Dis       Date:  2021-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.